Assertio Holdings, Inc.
Assertio Holdings, Inc. (ASRT) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
asrt · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Assertio Holdings, Inc. (ASRT) measures how much investors pay for each dollar of the company's trailing earnings. ASRT's current PE ratio of N/A is calculated by dividing its stock price of $23.43 by its TTM earnings per share of -$5.55.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 7 fiscal years · Front-end computedMinQ1 · 25%6.2x
MedianQ3 · 75%85.8x
Max
At N/A, ASRT's current P/E is lower than in 0% of its annual fiscal year readings over the past 7 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Assertio Holdings, Inc.You ASRT | $151M | N/A | — | -$5.55 |
 Acrivon Therapeutics, Inc. Common Stock ACRV | $44M | N/A | — | -$2.02 |
 Fortress Biotech, Inc. FBIO | $95M | 14.98x | — | $0.24 |
 InterCure Ltd. INCR | $54M | N/A | — | -$0.63 |
 Lite Strategy, Inc. LITS | $26M | N/A | — | -$2.39 |
 Pulmonx Corporation LUNG | $63M | N/A | — | -$1.33 |
 Nutriband Inc. NTRB | $43M | N/A | — | -$0.71 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-4.74 | — | |
2024-12-31 FY2024 | — | $-3.40 | — | |
2023-12-31 FY2023 | — | $-70.10 | — | |
2022-12-31 FY2022 | 1.84x | $34.98 | — | |
2021-12-31 FY2021 | — | $-0.45 | — | |
2020-12-31 FY2020 | — | $-16.11 | — | |
2019-12-31 FY2019 | — | $-184.29 | — | |
2018-12-31 FY2018 | 6.24x | $34.71 | — | |
2017-12-31 FY2017 | — | $-98.08 | — | |
2016-12-31 FY2016 | — | $-87.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Assertio Holdings, Inc. (ASRT) measures how much investors pay for each dollar of the company's trailing earnings. ASRT's current PE ratio of N/A is calculated by dividing its stock price of $23.43 by its TTM earnings per share of -$5.55.
Frequently asked questions
ASRT pe ratio · 6 questionsASRT's current PE ratio is N/A as of 2026-06-09, based on a stock price of $23.43 and TTM EPS of -$5.55. Data sourced from Financial Modeling Prep via ASRT's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Assertio Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09